NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Quantitative Bright-Field Microscopy Combined with Deep Neural Networks Predict Live Tissue Function
Published
Author(s)
Carl Simon, Nicholas J. Schaub, Petru S. Manescu, Sarala Padi, Mylene Simon, Peter Bajcsy, Nathan A. Hotaling, Joe Chalfoun, Mohamed Ouladi, Qin Wan, Kapil Bharti, Ruchi Sharma
Abstract
Progressive increases in the number of cell therapies in the preclinical and clinical phases has prompted the need for reliable and non-invasive assays to validate transplant function in clinical biomanufacturing. Here, we developed a robust characterization platform composed of quantitative bright- field absorbance microscopy (QBAM) and deep neural networks (DNNs) to non-invasively predict tissue function and cellular donor identity. The platform was validated using clinical-grade induced pluripotent stem cell derived retinal pigment epithelial cells (iRPE). QBAM images of iRPE were used to train DNNs that predicted iRPE monolayer transepithelial resistance (R2=0.97), predicted polarized VEGF secretion (R2=0.89), and matched iRPE monolayers to the iPSC donors (accuracy=85%). DNN predictions were supplemented with traditional machine learning algorithms that identified shape and texture features of single cells that were used to predict tissue function and iPSC donor identity. These results demonstrate non-invasive cell therapy characterization can be achieved with quantitative bright-field microscopy and machine learning.
Simon, C.
, Schaub, N.
, Manescu, P.
, Padi, S.
, Simon, M.
, Bajcsy, P.
, Hotaling, N.
, Chalfoun, J.
, Ouladi, M.
, Wan, Q.
, Bharti, K.
and Sharma, R.
(2020),
Quantitative Bright-Field Microscopy Combined with Deep Neural Networks Predict Live Tissue Function, Biomaterials, [online], https://doi.org/10.1172/JCI131187, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=926975
(Accessed October 13, 2025)